Probiotix Health Plc · AQUIS:PBX
Probiotix Health — Fact Sheet (August 2026)
10 slides from Probiotix Health's fact sheet, August 2026
Slide 1: Reformulating for the future of Cholesterol Health
Reformulating for the future of Cholesterol Health
Slide 2: The Cholesterol Market Is Changing
The Cholesterol Market Is Changing The forces shaping cholesterol innovation are no longer driven by efficacy alone, they're being redefined by regulation, consumer expectations and commercial strategy. Regulatory Change Consumer Behaviour Commercial Pressure Market Opportunity Monacolin K - EFSA re
Slide 3: Yesterday's Winning Ingredients Are Becoming Tomorrow's Commercial Risk
Yesterday's Winning Ingredients Are Becoming Tomorrow's Commercial Risk W H AT D O W E C U R R E N T K N O W ? Regulatory Products Portfolio Monacolin K restrictions discontinuation disruptions Reformulation The Commercial Reality Brands now need steer to: ✓ Review cholesterol portfolios Increasing
Slide 4: What should a future cholesterol ingredient look like?
What should a future cholesterol ingredient look like? T HE MA R K E T HA S C HA N GE D… S HOUL DN’T TH E S ELEC TION C RITERA AL SO CH ANGE? 1. Provide Confidence 2. Deliver Proof Why Mechanism Matters Ideal As regulatory expectations evolve, ingredients supported Cholesterol by a clearly understoo
Slide 5: LPLDL: Redefining Cholesterol Support Through Microbiome Science
LPLDL® REDEFINING CH OLESTEROL SU PPORT T HROUG H MI C ROBIOM E S CI EN CE For decades, cholesterol ingredients have largely focused on one outcome: Lower cholesterol. LP LDL® was developed with a different Targeting cardiometabolic purpose. Rather than only lowering health through the gut cholester
Slide 6: Global Presence
Global Presence LPLDL® is already supporting successful commercial products across multiple international markets. Ⓒ 2024 Probiotix Health Limited. All Rights Reserved
Slide 7: Global Recognitions & Industry Credentials
Memberships & Associations: Global Recognitions & Industry Credentials International Probiotics Association Awards & Events: Scientific Recognition: 5 Clinical trials LPLDL® has 27 overlapping Global partnerships patents
Slide 8: Research partners
Research partners We actively partner with renowned universities, clinical research centers, and hospitals to drive scientific validation and clinical credibility. These collaborations enable: - Rigorous, peer-reviewed human intervention studies. - Access to cutting-edge research environments and me
Slide 9: Let's Discuss Your Reformulation Strategy
Let's Discuss Your Reformulation Strategy B O O K A ME E T I NG WI T H OU R T E AM T O E XP LO RE : How the cholesterol category is changing Where the commercial opportunity lies Why LP LDL® is emerging as a future-ready alternative The clinical evidence supporting LP LDL® How LP LDL® compares with
Slide 10: Get In Touch…
Kasper R. Hoffensetz Sales Manager, EMEA Get In Touch… +45 2216 3025 khoffensetz@probiotixhealth.com